Executive Summary
Carahsoft Technology Corp secured a $465M obligated delivery order from CMS (HHS) for income verification software, with $337M already outlayed and potential upside to $2.1B via options through 2028. This represents a major bullish signal for federal IT/software publishers amid healthcare admin digitization. Investors should monitor option exercises and outlays for revenue acceleration, tempered by firm-fixed-price margin risks.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Federal IT & Cybersecurity Contracts digest from March 28, 2026.
Investment Signals (1)
- Carahsoft lands $465M CMS software award with $2B upside (HIGH)▲
$336M outlayed to date on $465M obligation signals strong execution; options could drive total value to $2.066B by 2028.
Risk Flags (2)
- Execution [MEDIUM RISK]▼
Firm-fixed-price structure risks margin compression if costs overrun estimates.
- Market [HIGH RISK]▼
$1.6B in options beyond $465M obligation are not guaranteed and subject to exercise.
Opportunities (2)
- ◆
Remaining $128M outlays on $465M obligation plus $1.6B options through 2028.
- ◆
Expansion in CMS/HHS software publishing (NAICS 511210) and support services (PSC R499).
Sector Themes (1)
- ◆
CMS prioritizes software for income verification, signaling admin efficiency push.
Watch List (2)
- 👁
{"entity"=>"Carahsoft Technology Corp", "reason"=>"$465M obligation with 72% outlayed; $2B option upside pivotal for revenue.", "trigger"=>"Option exercises or outlay acceleration >$10M/quarter"}
- 👁
{"entity"=>"CMS/HHS IT spending", "reason"=>"Single large award highlights concentration in healthcare software.", "trigger"=>"New awards >$100M in NAICS 511210"}
Get daily alerts with 1 investment signals, 2 risk alerts, 2 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Federal IT & Cybersecurity Contracts
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals